Annual Total Debt
$51.62 M
+$50.73 M+5674.27%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual total debt is $51.62 million, with the most recent change of +$50.73 million (+5674.27%) on December 1, 2023.
- During the last 3 years, ORMP annual total debt has risen by +$51.62 million (+100.00%).
- ORMP annual total debt is now at all-time high.
Performance
ORMP Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$429.00 K
-$57.00 K-11.73%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly total debt is $429.00 thousand, with the most recent change of -$57.00 thousand (-11.73%) on September 1, 2024.
- Over the past year, ORMP quarterly total debt has dropped by -$51.19 million (-99.17%).
- ORMP quarterly total debt is now -99.44% below its all-time high of $76.00 million, reached on September 30, 2023.
Performance
ORMP Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ORMP Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5674.3% | -99.2% |
| 3 y3 years | +100.0% | -56.1% |
| 5 y5 years | +100.0% | +100.0% |
ORMP Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -99.4% | at low |
| 5 y | 5-year | at high | -100.0% | -99.4% | +472.0% |
| alltime | all time | at high | -100.0% | -99.4% | -100.0% |
Oramed Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $429.00 K(-11.7%) |
| Jun 2024 | - | $486.00 K(-98.5%) |
| Mar 2024 | - | $32.56 M(-36.9%) |
| Dec 2023 | $51.62 M(+5674.3%) | $51.62 M(-32.1%) |
| Sep 2023 | - | $76.00 M(>+9900.0%) |
| Jun 2023 | - | $724.00 K(-10.2%) |
| Mar 2023 | - | $806.00 K(-9.8%) |
| Dec 2022 | $894.00 K(+78.8%) | $894.00 K(-0.7%) |
| Sep 2022 | - | $900.00 K(-7.9%) |
| Jun 2022 | - | $977.00 K(-11.8%) |
| Mar 2022 | - | $1.11 M(+119.8%) |
| Dec 2021 | $500.00 K(-6.2%) | - |
| Nov 2021 | - | $504.00 K(-5.4%) |
| Aug 2021 | $533.00 K(>+9900.0%) | $533.00 K(-4.8%) |
| May 2021 | - | $560.00 K(-7.9%) |
| Feb 2021 | - | $608.00 K(-5.0%) |
| Dec 2020 | $0.00(-100.0%) | - |
| Nov 2020 | - | $640.00 K(+753.3%) |
| Aug 2020 | $75.00 K(>+9900.0%) | $75.00 K(-15.7%) |
| May 2020 | - | $89.00 K(-10.1%) |
| Feb 2020 | - | $99.00 K(-6.6%) |
| Nov 2019 | - | $106.00 K(>+9900.0%) |
| Aug 2019 | $0.00(0.0%) | $0.00(0.0%) |
| May 2019 | - | $0.00(0.0%) |
| Feb 2019 | - | $0.00(0.0%) |
| Nov 2018 | - | $0.00(0.0%) |
| Aug 2018 | $0.00(0.0%) | $0.00(0.0%) |
| May 2018 | - | $0.00(0.0%) |
| Feb 2018 | - | $0.00(0.0%) |
| Nov 2017 | - | $0.00(0.0%) |
| Aug 2017 | $0.00(0.0%) | $0.00(0.0%) |
| May 2017 | - | $0.00(0.0%) |
| Feb 2017 | - | $0.00(0.0%) |
| Nov 2016 | - | $0.00(0.0%) |
| Aug 2016 | $0.00(0.0%) | $0.00(0.0%) |
| May 2016 | - | $0.00(0.0%) |
| Feb 2016 | - | $0.00(0.0%) |
| Nov 2015 | - | $0.00(0.0%) |
| Aug 2015 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2015 | - | $0.00(0.0%) |
| Feb 2015 | - | $0.00(0.0%) |
| Nov 2014 | - | $0.00(0.0%) |
| Aug 2014 | $0.00(0.0%) | $0.00(0.0%) |
| May 2014 | - | $0.00(0.0%) |
| Feb 2014 | - | $0.00(0.0%) |
| Nov 2013 | - | $0.00(0.0%) |
| Aug 2013 | $0.00(0.0%) | $0.00(0.0%) |
| May 2013 | - | $0.00(0.0%) |
| Feb 2013 | - | $0.00(0.0%) |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | $0.00(0.0%) | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Nov 2011 | - | $0.00(0.0%) |
| Aug 2011 | $0.00(0.0%) | $0.00(0.0%) |
| May 2011 | - | $0.00(0.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(0.0%) |
| Aug 2010 | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | - | $0.00(0.0%) |
| Nov 2009 | - | $0.00(0.0%) |
| Aug 2009 | $0.00(0.0%) | $0.00(0.0%) |
| May 2009 | - | $0.00(0.0%) |
| Feb 2009 | - | $0.00(0.0%) |
| Nov 2008 | - | $0.00(0.0%) |
| Aug 2008 | $0.00(-100.0%) | $0.00(0.0%) |
| May 2008 | - | $0.00(-100.0%) |
| Feb 2008 | - | $275.00 K(0.0%) |
| Nov 2007 | - | $275.00 K(0.0%) |
| Aug 2007 | $275.00 K(>+9900.0%) | $275.00 K(0.0%) |
| May 2007 | - | $275.00 K(+120.0%) |
| Feb 2007 | - | $125.00 K(>+9900.0%) |
| Nov 2006 | - | $0.00(0.0%) |
| Aug 2006 | $0.00(0.0%) | $0.00(0.0%) |
| May 2006 | - | $0.00(0.0%) |
| Feb 2006 | - | $0.00(0.0%) |
| Nov 2005 | - | $0.00 |
| Aug 2005 | $0.00 | - |
FAQ
- What is Oramed Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual total debt year-on-year change?
- What is Oramed Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly total debt year-on-year change?
What is Oramed Pharmaceuticals annual total debt?
The current annual total debt of ORMP is $51.62 M
What is the all time high annual total debt for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual total debt is $51.62 M
What is Oramed Pharmaceuticals annual total debt year-on-year change?
Over the past year, ORMP annual total debt has changed by +$50.73 M (+5674.27%)
What is Oramed Pharmaceuticals quarterly total debt?
The current quarterly total debt of ORMP is $429.00 K
What is the all time high quarterly total debt for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly total debt is $76.00 M
What is Oramed Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ORMP quarterly total debt has changed by -$51.19 M (-99.17%)